Tag: scientists

WARREN, N.J., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T cell therapeutics to treat infectious disease and cancers, today announced its top-line revenue forecast for its specialty care pipeline, projecting nearly $1 billion in revenue in its launch year and a cumulative 5-year estimate of between $18 billion and $22 billion. This forecast reflects the company’s unique, faster, and cost-efficient drug development model which has the potential to serve as a blueprint to ensure sustainable medical innovation for years to come.

TAIPEI, Taiwan, Aug. 06, 2025 (GLOBE NEWSWIRE) -- “More than ever, this is the moment for the intellect and efforts of Vietnamese, both domestic and abroad, to prove that we can achieve what once seemed impossible.” This heartfelt call from CT Group’s Chairman resonated throughout the "Vietnam Dreams Come True" conference held on July 25, 2025, in Taiwan, inspiring a community of intellectuals, experts, and overseas Vietnamese living, studying, and working abroad.

Tokyo, Japan and Cambridge, UK, 6 August 2025 – Nxera Pharma Co., Ltd. (“Nxera”; TSE: 4565) a technology-powered biopharmaceutical company, today announces the launch of a broad new pipeline strategically focused on advancing next-generation therapies for obesity and associated metabolic disorders.